MICHAEL RITMILLER: Open Payments
NPI 1063473601 · OWINGS MILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$983 in 39 payments from 10 companies in 2025. Trend: 2023 $1,606 · 2024 $1,456 · 2025 $983
Food & beverage: $983
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $371 |
| Sumitomo Pharma America, Inc. | 12 | $359 |
| Endo USA, Inc. | 4 | $73 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $40 |
| Janssen Biotech, Inc. | 1 | $31 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Medtronic, Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| COLOPLAST CORP | 1 | $19 |
| 180 Medical, Inc. | 1 | $16 |
Products named: BOTOX, GEMTESA, AVEED, JOURNAVX, ERLEADA, KEYTRUDA, INTERSTIM, Nubeqa.
Industry payments across MD — which companies pay providers there.
